The Psychiatric‐Metabolic Interface: Exploring the Interplay Between Mental Disorders and Metabolic Syndrome

Psychiatric disorders affect a person′s mental health, causing emotional and physical disturbances. Metabolic syndrome (MetS) is a medical condition characterized by metabolic abnormalities and health complications. Research suggests that individuals with specific psychiatric conditions are more likely to develop MetS. This review explores the intricate relationship between psychiatric disorders and MetS, emphasizing their shared biological, behavioral, and environmental foundations. Psychiatric conditions such as schizophrenia, depression, bipolar disorder, anxiety, dementia, PTSD, and alcohol use disorder are analyzed for their impact on metabolic health. Evidence highlights the role of genetic predispositions, inflammatory processes, neuroendocrine dysfunctions, and lifestyle factors in linking psychiatric symptoms to MetS components, including obesity, insulin resistance, dyslipidemia, and hypertension. The paper further examines the exacerbation of MetS through pharmacological treatments like antipsychotics and mood stabilizers, which disrupt glucose and lipid metabolism. Additionally, mechanisms such as hypothalamic–pituitary–adrenal axis dysregulation, oxidative stress, and chronic inflammation are explored as shared pathways between these conditions. The bidirectional relationship between cognitive decline and MetS is also discussed, underlining its role in neurodegenerative diseases like Alzheimer′s. By synthesizing current evidence, this research underscores the urgent need for integrated approaches addressing both psychiatric and metabolic health, paving the way for improved therapeutic strategies and patient outcomes.